福莫特罗-话题@MedSci

#福莫特罗#

7篇内容 | 723人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2188170, encodeId=5b4b21881e0b3, content=<a href='/topic/show?id=77d9855258f' target=_blank style='color:#2F92EE;'>#腹主动脉瘤#</a> <a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a> <a href='/topic/show?id=b53611133882' target=_blank style='color:#2F92EE;'>#张运#</a>, objectTitle=Adv Sci：张澄/张运/章萌团队发现β2受体激动剂福莫特罗抑制腹主动脉瘤的有益作用, objectType=article, longId=813875, objectId=55648138e50d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240218/e3caf1384b6a41e8ba555d756803804a.jpg, objectUrl=/article/show_article.do?id=55648138e50d, replyNumber=0, likeNumber=26, createdTime=2024-02-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=55648138e50d, moduleTitle=Adv Sci：张澄/张运/章萌团队发现β2受体激动剂福莫特罗抑制腹主动脉瘤的有益作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55648138e50d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187830, encodeId=8731218e83076, content=<a href='/topic/show?id=77d9855258f' target=_blank style='color:#2F92EE;'>#腹主动脉瘤#</a> <a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a> <a href='/topic/show?id=edd21655a4' target=_blank style='color:#2F92EE;'>#AAA#</a>, objectTitle=Adv Sci 山东大学齐鲁医院张澄/张运/章萌团队发现β2受体激动剂福莫特罗抑制腹主动脉瘤的有益作用, objectType=article, longId=813594, objectId=4f5581359438, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=4f5581359438, replyNumber=0, likeNumber=26, createdTime=2024-02-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=4f5581359438, moduleTitle=Adv Sci 山东大学齐鲁医院张澄/张运/章萌团队发现β2受体激动剂福莫特罗抑制腹主动脉瘤的有益作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f5581359438)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1625297, encodeId=2880162529e44, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=Lancet：布地奈德-福莫特罗联合治疗用于轻中度哮喘患者恶化预防, objectType=article, longId=178254, objectId=242c1e8254fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=242c1e8254fc, replyNumber=0, likeNumber=47, createdTime=2019-08-29, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=242c1e8254fc, moduleTitle=Lancet：布地奈德-福莫特罗联合治疗用于轻中度哮喘患者恶化预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=242c1e8254fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625296, encodeId=e4b01625296c8, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=NEJM：按需吸入布地奈德-福莫特罗治疗轻度哮喘, objectType=article, longId=138403, objectId=0497138403c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0497138403c2, replyNumber=0, likeNumber=47, createdTime=2018-05-19, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0497138403c2, moduleTitle=NEJM：按需吸入布地奈德-福莫特罗治疗轻度哮喘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0497138403c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625295, encodeId=0aff162529559, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=Lancet：倍氯米松、福莫特罗以及格隆溴铵三联吸入治疗可有效缓解中重度COPD患者症状, objectType=article, longId=129448, objectId=5aa612944846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5aa612944846, replyNumber=0, likeNumber=43, createdTime=2018-02-11, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5aa612944846, moduleTitle=Lancet：倍氯米松、福莫特罗以及格隆溴铵三联吸入治疗可有效缓解中重度COPD患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5aa612944846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625294, encodeId=b3c5162529459, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性, objectType=article, longId=102482, objectId=fcbd10248200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcbd10248200, replyNumber=0, likeNumber=40, createdTime=2017-06-21, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcbd10248200, moduleTitle=Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcbd10248200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625293, encodeId=57bf1625293dc, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=Respir Med：使用布地奈德/福莫特罗中国患者哮喘控制水平如何？, objectType=article, longId=102481, objectId=779e10248115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=779e10248115, replyNumber=0, likeNumber=38, createdTime=2017-06-21, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=779e10248115, moduleTitle=Respir Med：使用布地奈德/福莫特罗中国患者哮喘控制水平如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=779e10248115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625292, encodeId=e210162529221, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=NEJM：布地奈德—福莫特罗可减少哮喘加重的风险, objectType=article, longId=76422, objectId=ee04e6422d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee04e6422d1, replyNumber=0, likeNumber=37, createdTime=2016-09-02, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee04e6422d1, moduleTitle=NEJM：布地奈德—福莫特罗可减少哮喘加重的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee04e6422d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1625291, encodeId=ad8516252910c, content=<a href='/topic/show?id=028ee4684da' target=_blank style='color:#2F92EE;'>#福莫特罗#</a>, objectTitle=Respirology：布地奈德/福莫特罗联合用药治疗COPD效果更佳, objectType=article, longId=19034, objectId=292219034ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=292219034ad, replyNumber=0, likeNumber=42, createdTime=2013-05-22, rootId=0, userName=nakerunner, userId=ced620728635, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=292219034ad, moduleTitle=Respirology：布地奈德/福莫特罗联合用药治疗COPD效果更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=292219034ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

福莫特罗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#腹主动脉瘤# #福莫特罗# #张运#

Adv Sci：张澄/张运/章萌团队发现β2受体激动剂福莫特罗抑制腹主动脉瘤的有益作用

2024-02-19发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#腹主动脉瘤# #福莫特罗# #AAA#

Adv Sci 山东大学齐鲁医院张澄/张运/章萌团队发现β2受体激动剂福莫特罗抑制腹主动脉瘤的有益作用

2024-02-17发表于陕西省

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

Lancet：布地奈德-福莫特罗联合治疗用于轻中度哮喘患者恶化预防

2019-08-29

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

NEJM：按需吸入布地奈德-福莫特罗治疗轻度哮喘

2018-05-19

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

Lancet：倍氯米松、福莫特罗以及格隆溴铵三联吸入治疗可有效缓解中重度COPD患者症状

2018-02-11

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性

2017-06-21

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

Respir Med：使用布地奈德/福莫特罗中国患者哮喘控制水平如何？

2017-06-21

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

NEJM：布地奈德—福莫特罗可减少哮喘加重的风险

2016-09-02

nakerunner (审核中...)

前往app查看评论内容

#福莫特罗#

Respirology：布地奈德/福莫特罗联合用药治疗COPD效果更佳

2013-05-22

科室
- - 订阅+
  - 更多科室
工具
服务